Moneycontrol PRO
UPCOMING EVENT:Learn how to add equities to your portfolio through ETFs. Don’t miss the webinar on Oct 19, 11.30am. Register Now!
you are here: HomeNewsIndia

Cumulative Covid vaccine doses administered in India cross 59.47 crore: Govt

As on day-221 of the vaccination drive, 38,29,038 were vaccinated for first dose and 16,38,513 beneficiaries received the second dose of vaccine as per the provisional report till 7 pm, according to health ministry data.

August 24, 2021 / 10:45 PM IST
Representative image.

Representative image.

The cumulative COVID-19 vaccine doses administered in the country has crossed 59.47 crore so far, the Union health ministry said on Tuesday. More than 54 lakh vaccine doses have been administered on Tuesday, according to the 7 pm provisional report.

Final reports would be completed for the day by late Tuesday night, the ministry said.

Cumulatively, 22,33,59,860 individuals in the age group of 18-44 years across states and union territories have received their first dose and 2,11,37,082 have received their second dose since the start of the third phase of the vaccination drive, according to health ministry data.

As on day-221 of the vaccination drive, 38,29,038 were vaccinated for first dose and 16,38,513 beneficiaries received the second dose of vaccine as per the provisional report till 7 pm, according to health ministry data.

The countrywide vaccination drive was rolled out on January 16 with healthcare workers (HCWs) getting inoculated and vaccination of frontline workers (FLWs) started from February 2.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The next phase of COVID-19 vaccination commenced from March 1 for those over 60 years of age and for people aged 45 and above with specified co-morbid conditions.

India launched vaccination for all people aged more than 45 from April 1.

The government then decided to expand its vaccination drive by allowing everyone above 18 eligible to be vaccinated from May 1.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Aug 24, 2021 10:44 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark